Jphm.Am

JPHM.AM maintains a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.13, suggesting it has just enough current assets to cover its current liabilities. However, the company's cash and equivalents amount to only 12,500 JOD, which is significantly lower than its long-term debt of 16,517,840 JOD, resulting in a net cash position that is negative after subtracting total debt.

In terms of profitability, JPHM.AM reports a return on equity (ROE) of 16.8% and a return on assets (ROA) of 8.7%. These figures are strong indicators of the company's ability to generate returns for its shareholders and effectively utilize its assets. The operating margin, calculated as operating income divided by revenue, is 18.7%, which is a key metric for assessing operational efficiency in the pharmaceutical industry.

The company's revenue is primarily derived from its pharmaceutical operations, with no specific segments or geographic regions disclosed in the available data. This lack of segmentation makes it difficult to assess the concentration of revenue across different product lines or markets. However, the company's total revenue of 23,562,080 JOD suggests a significant presence in the pharmaceutical market.

Looking at the growth trajectory, JPHM.AM has reported a net income of 4,128,390 JOD and a free cash flow of 4,458,840 JOD. The company's capital expenditure of -619,840 JOD indicates a reduction in capital spending, which could be a strategic move to preserve cash. The recent actual EPS of -0.23 JOD and revenue of 9,980,000 JOD suggest some volatility in earnings, which may impact future growth expectations.

The risk assessment for JPHM.AM highlights a medium liquidity risk and a low dilution risk. The company's liquidity position is constrained by its low cash reserves relative to its debt obligations. The dilution risk is considered low, as there is no indication of significant share issuance or dilution potential in the near term. The company's financial structure and operational performance suggest a stable but cautious outlook.

Recent events and filings indicate that JPHM.AM has maintained a consistent financial performance, with no major disruptions reported. The company's financial statements and disclosures provide a transparent view of its operations, which is essential for investors and stakeholders to make informed decisions.